BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 37084840)

  • 1. GRIN2D knockdown suppresses the progression of lung adenocarcinoma by regulating the E2F signalling pathway.
    Chen Z; Song Y; Li P; Gao W
    Cell Signal; 2023 Jul; 107():110685. PubMed ID: 37084840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BZW2 Modulates Lung Adenocarcinoma Progression through Glycolysis-Mediated IDH3G Lactylation Modification.
    Wang M; He T; Meng D; Lv W; Ye J; Cheng L; Hu J
    J Proteome Res; 2023 Dec; 22(12):3854-3865. PubMed ID: 37955350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RTKN2 Inhibits the Growth, Migration, Invasion and Glycolysis of Lung Adenocarcinoma Cells by Inactivating the NF-κB Signalling Pathway.
    Wang N; Wang J
    Biochem Genet; 2023 Oct; 61(5):2135-2148. PubMed ID: 36952123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The E2F1/MELTF axis fosters the progression of lung adenocarcinoma by regulating the Notch signaling pathway.
    Zhang L; Shi L
    Mutat Res; 2023; 827():111837. PubMed ID: 37820570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GIMAP7 inhibits epithelial-mesenchymal transition and glycolysis in lung adenocarcinoma cells via regulating the Smo/AMPK signaling pathway.
    Cui L; Shen Y; Duan S; Ding Q; Wang Y; Yang W; Chen Y
    Thorac Cancer; 2024 Feb; 15(4):286-298. PubMed ID: 38151913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RHOV promotes lung adenocarcinoma cell growth and metastasis through JNK/c-Jun pathway.
    Zhang D; Jiang Q; Ge X; Shi Y; Ye T; Mi Y; Xie T; Li Q; Ye Q
    Int J Biol Sci; 2021; 17(10):2622-2632. PubMed ID: 34326698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LncRNA FAM83A-AS1 facilitates tumor proliferation and the migration via the HIF-1α/ glycolysis axis in lung adenocarcinoma.
    Chen Z; Hu Z; Sui Q; Huang Y; Zhao M; Li M; Liang J; Lu T; Zhan C; Lin Z; Sun F; Wang Q; Tan L
    Int J Biol Sci; 2022; 18(2):522-535. PubMed ID: 35002507
    [No Abstract]   [Full Text] [Related]  

  • 8. PSMA5 contributes to progression of lung adenocarcinoma in association with the JAK/STAT pathway.
    Lu F; Zhou J; Chen Q; Zhu J; Zheng X; Fang N; Qiao L
    Carcinogenesis; 2022 Aug; 43(7):624-634. PubMed ID: 35605971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of BCCIP predicts an unfavorable prognosis and promotes the proliferation and migration of lung adenocarcinoma.
    Shi J; Lv X; Li W; Ming Z; Zeng L; Yuan J; Chen Y; Liu B; Yang S
    Thorac Cancer; 2021 Sep; 12(17):2324-2338. PubMed ID: 34297484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA repair/recombination protein 54L promotes the progression of lung adenocarcinoma by activating mTORC1 pathway.
    Liu C; Ren W; Zhang Z; Guan J
    Hum Cell; 2023 Jan; 36(1):421-433. PubMed ID: 36454390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synaptotagmin 12 (SYT12) Gene Expression Promotes Cell Proliferation and Progression of Lung Adenocarcinoma and Involves the Phosphoinositide 3-Kinase (PI3K)/AKT/Mammalian Target of Rapamycin (mTOR) Pathway.
    Liu K; Luo J; Shao C; Ren Z; Sun S; Zhu Y; Zhou H; Jiang Z; Li X; Gu W; Xu Y; Qiang Y; Ren B; Xu L; Wu H; Shen Y
    Med Sci Monit; 2020 Feb; 26():e920351. PubMed ID: 32108133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of SEC61G in lung adenocarcinoma: a comprehensive study based on bioinformatics and in vitro validation.
    Zheng Q; Wang Z; Zhang M; Yu Y; Chen R; Lu T; Liu L; Ma J; Liu T; Zheng H; Li H; Li J
    BMC Cancer; 2021 Nov; 21(1):1216. PubMed ID: 34774014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LPCAT1 promotes brain metastasis of lung adenocarcinoma by up-regulating PI3K/AKT/MYC pathway.
    Wei C; Dong X; Lu H; Tong F; Chen L; Zhang R; Dong J; Hu Y; Wu G; Dong X
    J Exp Clin Cancer Res; 2019 Feb; 38(1):95. PubMed ID: 30791942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ANKRD22 promotes M2 polarization in lung adenocarcinoma macrophages via the glycolytic pathway.
    Cao J; Zhang H; Wei X; Zhou H
    Chem Biol Drug Des; 2024 Jan; 103(1):e14445. PubMed ID: 38230786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EphA10 drives tumor progression and immune evasion by regulating the MAPK/ERK cascade in lung adenocarcinoma.
    Zhao W; Liu L; Li X; Xu S
    Int Immunopharmacol; 2022 Sep; 110():109031. PubMed ID: 35839564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Knockdown of microsomal glutathione S-transferase 1 inhibits lung adenocarcinoma cell proliferation and induces apoptosis.
    Zeng B; Ge C; Li R; Zhang Z; Fu Q; Li Z; Lin Z; Liu L; Xue Y; Xu Y; He J; Guo H; Li C; Huang W; Song X; Huang Y
    Biomed Pharmacother; 2020 Jan; 121():109562. PubMed ID: 31707341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CCNE1 Promotes Progression and is Associated with Poor Prognosis in Lung Adenocarcinoma.
    Ma G; Yang L; Dong J; Zhang L
    Curr Pharm Biotechnol; 2022; 23(9):1168-1178. PubMed ID: 34792009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mex3a interacts with LAMA2 to promote lung adenocarcinoma metastasis via PI3K/AKT pathway.
    Liang J; Li H; Han J; Jiang J; Wang J; Li Y; Feng Z; Zhao R; Sun Z; Lv B; Tian H
    Cell Death Dis; 2020 Aug; 11(8):614. PubMed ID: 32792503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Actin-like protein 8 promotes cell proliferation, colony-formation, proangiogenesis, migration and invasion in lung adenocarcinoma cells.
    Ma S; Wang X; Zhang Z; Liu D
    Thorac Cancer; 2020 Mar; 11(3):526-536. PubMed ID: 31962007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. KIAA1429 promotes tumorigenesis and gefitinib resistance in lung adenocarcinoma by activating the JNK/ MAPK pathway in an m
    Lin X; Ye R; Li Z; Zhang B; Huang Y; Du J; Wang B; Meng H; Xian H; Yang X; Zhang X; Zhong Y; Huang Z
    Drug Resist Updat; 2023 Jan; 66():100908. PubMed ID: 36493511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.